Merck & Co., Inc - Company Snapshot & SWOT Analysis

Publication ID:

NAV0319008

Publication Date:

March 06, 2019

Pages:

Countries:

Global [1]

As per NAVADHI Market Research, the global pharmaceutical industry [2] will we worth USD 1.57 trillion by 2023.

Merck & Co., Inc. is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. The Company’s operations are principally managed on a products basis and include four operating segments, which are the Pharmaceutical, Animal Health, Healthcare Services and Alliances segments.

Merck & Co., Inc. 2018 Revenue Performance at a glance

The Pharmaceutical segment includes human health pharmaceutical and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices. The Company sells these human health vaccines primarily to physicians, wholesalers, physician distributors and government entities.

Merck reported revenue of USD 42.294 billion for the FY 2018 which saw an increase of 5.41% compared to FY 2017. This revenue is expected to increase by 5.68% and reach USD 44.700 billion by FY 2019.

Merck & Co., Inc. registered highest revenue from oncology (Keytruda, Emend, Temodar, Alliance revenue – Lynparza and Alliance revenue - Lenvima) at USD 8.243 billion which accounted for 21.87% of its total pharmaceuticals sales in FY 2018.

Looking into 2019, Merck said it sees non-GAAP earnings of between $4.57 and $4.72 per share on worldwide sales of between $43.2 billion and $44.7 billion.

Spanning over 29 pages and 13 exhibits, “Merck & Co., Inc - Company Snapshot & SWOT Analysis” report provides value chain analysis, financial performance, business strategy and SWOT analysis for company.

Scope of the Merck & Co., Inc - Company Snapshot & SWOT Analysis Report

This report provides detailed information about Merck & Co., Inc including value chain analysis, financial performance, business strategy and SWOT analysis.
he report identifies the growth drivers and inhibitors for global pharmaceutical market.
This report provides information about current and future trends for global pharmaceutical market.

1. Executive Summary

Scope of the Merck & Co., Inc.- Company Snapshot & SWOT Analysis Report

Research Methodology

2. Growth Drivers and Inhibitors for Global Pharmaceuticals Market

3. Company Profile

3.1 Merck & Co., Inc.

3.1.1. Company Profile

3.1.2 Merck & Co., Inc. in Global Pharmaceuticals Manufacturing Value Chain

3.1.3 Merck & Co., Inc.: Financial Performance

3.1.3.1 Merck & Co., Inc.: Overall Revenue FY 2013-FY 2019 (in USD billion)

3.1.3.2 Merck & Co., Inc.: Division-Wise Revenue FY 2018 (in USD billion)

3.1.3.3 Merck & Co., Inc.: Geography-Wise Revenue FY 2018 (in USD billion)

3.1.3.4 Merck & Co., Inc.: Therapy Area-Wise Revenue FY 2018 (in USD billion)

3.1.4 Merck & Co., Inc.: Business Strategy

3.1.4.1 Product Level Strategy

3.1.5 SWOT Analysis of Merck & Co., Inc.

Strengths

Weaknesses

Opportunities

Threats

4. Current and Future Trends in Pharmaceutical Market

List of Exhibits

Notes

List of Exhibits

Exhibit 2.1 Growth Drivers and Inhibitors for Global Pharmaceuticals Market

Exhibit 3.1 Key Information of Merck & Co.

Exhibit 3.2 Contact Information of Merck & Co.

Exhibit 3.3 Merck & Co., Inc. in Global Pharmaceuticals Manufacturing Value Chain

Exhibit 3.4 Revenue of Merck & Co., Inc. FY 2013- FY 2019 (in USD billion)

Exhibit 3.5 Revenue Growth of Merck & Co., Inc. FY 2014-FY 2019 (in %)

Exhibit 3.6 Division-Wise Revenue of Merck & Co., Inc. in FY 2018 (in USD billion)

Exhibit 3.7 Pharmaceuticals Division Revenue of Merck & Co., Inc. FY 2013- FY 2018 (in USD billion)

Exhibit 3.8 Animal Health Division Revenue of Merck & Co., Inc. FY 2013- FY 2018 (in USD billion)

Exhibit 3.9 Geography-Wise Revenue of Merck & Co., Inc. in FY 2018 (in USD billion)

Exhibit 3.10 Therapy Area-Wise Revenue of Merck & Co., Inc. in FY 2018 (in USD billion)

Exhibit 3.11 Business Division, Therapy Area and Geography Area-Wise Revenue of Merck & Co., Inc. FY 2018 (in USD billion)

Exhibit 3.12 SWOT Analysis of Merck & Co., Inc.

Merck & Co., Inc.

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Enterprise license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Enterprise license fee.

Enterprise License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.